Human C1-esterase inhibitor Completed Phase 2 Trials for Antibody Mediated Rejection of Kidney Transplant Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02936479C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection